2-iodo-6-chloro-9-(β-D-ribofuranosyl)purine | 313477-85-9
分子结构分类
中文名称
——
中文别名
——
英文名称
2-iodo-6-chloro-9-(β-D-ribofuranosyl)purine
英文别名
6-chloro-2-iodopurine 9-riboside；6-Chloro-2-iodopurine riboside；(2R,3R,4S,5R)-2-(6-chloro-2-iodopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
CAS
313477-85-9
化学式
C10H10ClIN4O4
mdl
——
分子量
412.571
InChiKey
BUXRSMOYQZICAU-UUOKFMHZSA-N
BEILSTEIN
——
EINECS
——
-
物化性质
-
计算性质
-
ADMET
-
安全信息
-
SDS
-
制备方法与用途
-
上下游信息
-
文献信息
-
表征谱图
-
同类化合物
-
相关功能分类
-
相关结构分类
物化性质
-
沸点：715.7±70.0 °C(Predicted)
-
密度：2.60±0.1 g/cm3(Predicted)
计算性质
-
辛醇/水分配系数(LogP)：0.9
-
重原子数：20
-
可旋转键数：2
-
环数：3.0
-
sp3杂化的碳原子比例：0.5
-
拓扑面积：114
-
氢给体数：3
-
氢受体数：7
SDS
上下游信息
-
上游原料
中文名称 英文名称 CAS号 化学式 分子量 6-氯鸟嘌呤核苷 2-Amino-6-chloropurine riboside 2004-07-1 C10H12ClN5O4 301.689 -
下游产品
中文名称 英文名称 CAS号 化学式 分子量 2-碘腺苷 2-iodoadenosine 35109-88-7 C10H12IN5O4 393.141 —— 2-iodo-N6-n-butyladenosine 313477-89-3 C14H20IN5O4 449.248 —— 2-iodo-N6-tetrahydrofurfuryladenosine 313477-90-6 C15H20IN5O5 477.259 —— 2-iodo-N6-(2''-phenylethyl)adenosine 313477-86-0 C18H20IN5O4 497.292 —— 2-iodo-N6-[2''-(p-aminophenyl)ethyl]adenosine 313477-88-2 C18H21IN6O4 512.307 —— 2-iodo-N6-[2''-(p-hydroxyphenyl)ethyl]adenosine 313477-87-1 C18H20IN5O5 513.292 —— 2-iodo-N6-(1''-naphthylmethyl)adenosine 313477-91-7 C21H20IN5O4 533.325 —— (2R,3R,4S,5R)-2-[6-amino-2-(2-aminoethylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol 77112-18-6 C12H19N7O4 325.327 —— 2-(2-hydroxy-ethylamino)-adenosine 56720-65-1 C12H18N6O5 326.312 —— N2-Propyl-2-aminoadenosin 35109-89-8 C13H20N6O4 324.34 —— 2-iodo-9-(2',3'-O-isopropylidene-β-D-ribofuranosyl)-N6-methyladenine 560071-54-7 C14H18IN5O4 447.233 —— 2-[(4''-hydroxybutyl)amino]adenosine —— C14H22N6O5 354.366 —— 2-(n-butylamino)adenosine 255716-02-0 C14H22N6O4 338.366 —— 2-(n-amylamino)adenosine —— C15H24N6O4 352.393 —— (2R,3R,4S,5R)-2-[6-amino-2-(4-aminobutylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol 77112-19-7 C14H23N7O4 353.381 —— 2-[(2''-hydroxypropyl)amino]adenosine —— C13H20N6O5 340.339 —— N2-Cyclohexyl-2,6-diaminonebularin 53296-12-1 C16H24N6O4 364.404 —— 2-[(2'',3''-dihydroxypropyl)amino]adenosine —— C13H20N6O6 356.338 —— CGS 21223 56720-67-3 C18H22N6O4 386.41 —— (2R,3R,4S,5R)-2-[6-amino-2-(cyclopentylamino)purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol 57972-89-1 C15H22N6O4 350.377 —— 2-(benzylamino)adenosine 56720-66-2 C17H20N6O4 372.384 —— 2-[(cyclohexylmethyl)amino]adenosine —— C17H26N6O4 378.431 —— 2-[2-(4-aminophenyl)ethylamino]adenosine 161536-30-7 C18H23N7O4 401.425 —— 2-[[2''-(p-hydroxyphenyl)ethyl]amino]adenosine 124499-08-7 C18H22N6O5 402.41 —— 2-[(m-methylbenzyl)amino]adenosine —— C18H22N6O4 386.41 —— (2R,3R,4S,5R)-2-(6-Amino-2-((3-phenylpropyl)amino)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol 124499-05-4 C19H24N6O4 400.437 —— 2-(2-phenylpropylamino)-adenosine 124498-68-6 C19H24N6O4 400.437 —— (2R,3R,4S,5R)-2-[6-amino-2-[(2-hydroxy-2-phenylethyl)amino]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol 124498-53-9 C18H22N6O5 402.41 —— 2-{6-Amino-2-[2-(4-methoxy-phenyl)-ethylamino]-purin-9-yl}-5-hydroxymethyl-tetrahydro-furan-3,4-diol 124499-07-6 C19H24N6O5 416.437 —— 1-deoxy-1-(6-methylamino-2-iodo-9H-purin-9-yl)-2,3-O-isopropylidene-β-D-ribofuranuronic acid 918868-16-3 C14H16IN5O5 461.216 —— N6-n-butyl-2-[(cyclohexylmethyl)amino]adenosine —— C21H34N6O4 434.539 —— N6-(2-phenylethyl)-2-<(phenylethyl)amino>adenosine 120524-43-8 C26H30N6O4 490.562 —— N6-(2''-phenylethyl)-2-[[2''-(p-hydroxyphenyl)ethyl]amino]adenosine —— C26H30N6O5 506.561 —— N6-[2''-(p-hydroxyphenyl)ethyl]-2-[[2''-(p-hydroxyphenyl)ethyl]amino]adenosine —— C26H30N6O6 522.561 —— N6-tetrahydrofurfuryl-2-[(cyclohexylmethyl)amino]adenosine —— C22H34N6O5 462.549 —— N6-(1-naphthylmethyl)-2-<(phenylmethyl)amino>adenosine 120524-46-1 C28H28N6O4 512.568 —— (3aS,4S,6R,6aR)-6-(2-iodo-6-(methylamino)-9H-purin-9-yl)-N,2,2-trimethyltetrahydrofuro [3,4-d][1,3]dioxole-4-carboxamide 1196066-41-7 C15H19IN6O4 474.258 —— N6-(1''-naphthylmethyl)-2-[(cyclohexylmethyl)amino]adenosine —— C28H34N6O4 518.616 - 1
- 2
- 3
- 4